David Seth Goldberg, MD, MSCE
Instructor B of Medicine
Faculty Fellow, Clinical Center for Epidemiology and Biostatistics
Instructor , Department of Medicine, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Division of Gastroenterology
3400 Spruce Street
3 Ravdin
Philadelphia, PA 19104
Division of Gastroenterology
3400 Spruce Street
3 Ravdin
Philadelphia, PA 19104
Office: 215-349-8222
Education:
BA (Judaic Studies)
Brown University, 2001.
MD
Mount Sinai School of Medicine, 2005.
MSCE
University of Pennsylvania, 2011.
BA (Judaic Studies)
Brown University, 2001.
MD
Mount Sinai School of Medicine, 2005.
MSCE
University of Pennsylvania, 2011.
Post-Graduate Training
Intern in Internal Medicine, New York Presbyterian Hospital-Columbia University Medical Center, 2005-2006.
Resident in Internal Medicine, New York Presbyterian Hospital-Columbia University Medical Center, 2006-2008.
Fellow in Gastroenterology, Hospital of the University of Pennsylvania, 2008-2011.
Permanent linkIntern in Internal Medicine, New York Presbyterian Hospital-Columbia University Medical Center, 2005-2006.
Resident in Internal Medicine, New York Presbyterian Hospital-Columbia University Medical Center, 2006-2008.
Fellow in Gastroenterology, Hospital of the University of Pennsylvania, 2008-2011.
Selected Publications
Bittermann T, Makar G, Goldberg D. : Exception point applications for 15 points: An unintended consequence of the Share 15 policy. AASLD Liver Meeting November 2012 Notes: Oral presentation.Goldberg D, Halpern SD, Reese PP: Decreased organ donation consent rates among racial and ethnic minorities and older potential donors. AASLD Liver Meeting November 2012 Notes: Oral Presentation.
Lo Re V 3rd, Haynes K, Fortier K, Carbonari DM, Lewis JD, Strom BL, Forde KA, Goldberg D, Reddy KR, Roy J, Marks AR, De Boer J, Corley DA: Validity of diagnostic codes and liver-related laboratory abnormalities to identify acute liver failure among Kaiser Permanente patients with diagnoses of drug-induced hepatitis. 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 2012 Notes: Oral Abstract 450.
Goldberg D, Lewis JD, Halpern SD, Weiner M, Lo Re III V: Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database Pharmacoepidemiology and Drug Safety 21(7): 765-769, July 2012.
Ruebner R, Goldberg D*, Apt PL, Bahirwani R, Levine M, Sawinski D, Shults J, Bloom RD, Reese PP. *co-first author: Risk of End-Stage Renal Disease Among Liver Transplant Recipients with Pre-Transplant Renal Dysfunction. American Journal of Transplnatation July 2012.
Goldberg D, Bittermann T, Makar G: Lack of Standardization in Exception Points for Patients with Primary Sclerosing Cholangitis and Bacterial Cholangitis American Journal of Transplantation 12(6): 1603-9, June 2012.
Goldberg D, French B, Abt P, Feng S, Cameron AM: Increasing Disparity in Waitlist Mortality Rates with Increased MELD Scores for Candidates with Versus Without Hepatocellular Carcinoma. Liver Transplantation 18: 434-443, April 2012.
Goldberg D, French B, Abt P, Feng S, Cameron A: Increasing Disparity in Waitlist Mortality Rates with Increased MELD Scores for Candidates with Versus Without Hepatocellular Carcinoma. International Liver Transplant Congress 2012.
Goldberg D, Ruebner R, Abt PL, Bahirwani R, Levine M, Sawinski D, SHults J, Bloom RD, Reese PP: Risk of end-stage renal disease among liver transplant recipients with pre-transplant chronic kidney disease. American Transplant Congress 2012.
David Goldberg: Exception points for waitlisted liver transplant candidates with HCC: Do we need to reform the current allocation policy. Consumer Talk with Marion Joyce. AM 1490 WGCH. 2012.
